Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-06-13T05:18:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.5.4 to v3.5.5, indicating a new page version. The change reflects a version update and does not alter the study details displayed.
    Difference
    0.0%
    Check dated 2026-06-05T23:50:13.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's version rather than a substantive change to its content.
    Difference
    0.0%
    Check dated 2026-05-15T15:20:22.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page footer now shows an updated release/revision version (from v3.5.2 to v3.5.3) for the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-04-24T06:35:47.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown on the page, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:52:05.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T05:08:29.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.